CC(=O)O[C@H]1CCC2[C@@H]3CCC4C(=O)c5oncc5C[C@]4(C)C3CC[C@@]21C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?